COVID-19 and radiotherapy: potential new strategies for patients management with hypofractionation and telemedicine.
Eur Rev Med Pharmacol Sci
; 24(23): 12480-12489, 2020 12.
Article
in English
| MEDLINE | ID: covidwho-995004
ABSTRACT
COVID-19 disease is one of the biggest public health challenges in Italy and global healthcare facilities, including radiotherapy departments, faced an unprecedented emergency. Cancer patients are at higher risk of COVID-19 infection because of their immunosuppressive state caused by both tumor itself and anticancer therapy adopted. In this setting, the radiation therapy clinical decision-making process has been partly reconsidered; thus, to reduce treatment duration and minimize infection risk during a pandemic, hypofractionated regimens have been revised. Moreover, telemedicine shows its helpfulness in the radiotherapy field, and patients get the supportive care they need minimizing their access to hospitals. This review aims to point out the importance of hypofractionated RT and telemedicine in cancer patient management in the COVID-19 era.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Radiotherapy
/
Telemedicine
/
Radiation Oncology
/
Radiation Dose Hypofractionation
/
COVID-19
/
Neoplasms
Type of study:
Prognostic study
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Eur Rev Med Pharmacol Sci
Journal subject:
Pharmacology
/
Toxicology
Year:
2020
Document Type:
Article
Affiliation country:
Eurrev_202012_24044
Similar
MEDLINE
...
LILACS
LIS